Trigeminal neuralgia is not classified as an autoimmune disease. It is a neuropathic pain disorder, and in 80% to 90% of cases, the cause is a blood vessel pressing against the trigeminal nerve near the brainstem. However, the relationship between trigeminal neuralgia and the immune system is more nuanced than a simple “no,” because autoimmune conditions like multiple sclerosis, lupus, and Sjögren’s syndrome can directly trigger trigeminal neuralgia as a secondary symptom.
What Actually Causes Trigeminal Neuralgia
The trigeminal nerve carries sensation from your face to your brain. When a blood vessel, most often the superior cerebellar artery, presses against this nerve near the point where it enters the brainstem, it damages the nerve’s protective insulation (myelin). That damage causes the nerve to misfire, producing the intense, shock-like facial pain that defines the condition. This mechanism, called neurovascular compression, accounts for the vast majority of cases. Other blood vessels that can compress the nerve include the petrosal vein and the anterior inferior cerebellar artery.
The International Classification of Headache Disorders divides trigeminal neuralgia into two broad categories. Classical trigeminal neuralgia is caused by vascular compression. Secondary trigeminal neuralgia is caused by a structural problem affecting the nerve, such as a demyelinating plaque from multiple sclerosis, a tumor, or a skull base abnormality. Up to 15% of trigeminal neuralgia patients fall into the secondary category.
How Autoimmune Diseases Can Trigger It
While trigeminal neuralgia itself is not autoimmune, it can appear as a symptom of several autoimmune conditions. The most well-established link is with multiple sclerosis, which is the underlying cause in roughly 2% to 4% of all trigeminal neuralgia patients. MS is a chronic inflammatory disease where the immune system attacks myelin in the central nervous system. When a demyelinating plaque forms along the intrapontine segment of the trigeminal nerve (the stretch that runs through the brainstem), the result can be trigeminal neuralgia.
Trigeminal neuralgia caused by MS has a few distinctive features compared to the classical form. The pain is bilateral (affecting both sides of the face) in about 18% of MS-related cases, which is unusual for classical trigeminal neuralgia. Sensory deficits, like reduced ability to feel touch on the affected side, occur in about 37% of secondary cases. Neurophysiological testing of the trigeminal nerve is abnormal in 89% of MS patients with TN, compared to only 3% of those with the classical form. Some MS patients also have vascular compression on top of the demyelinating plaque, suggesting two overlapping sources of nerve damage.
Beyond MS, trigeminal neuralgia has been reported in patients with systemic lupus erythematosus, systemic sclerosis (scleroderma), Sjögren’s syndrome, mixed connective tissue disease, and polymyositis/dermatomyositis. These associations are rarer. One study of 81 patients with various connective tissue diseases found trigeminal sensory neuropathy in 26% of those with mixed connective tissue disease, 19% with scleroderma, 2% with Sjögren’s syndrome, 2% with rheumatoid arthritis, and 1% with dermatomyositis. In some reported cases, trigeminal neuralgia was the very first symptom that led to a diagnosis of the underlying autoimmune condition.
Why the Immune System Still Matters
Even in classical trigeminal neuralgia caused by vascular compression rather than an autoimmune disease, inflammation plays a role in the pain process. Research has found that several inflammatory signaling molecules are linked to trigeminal neuralgia risk. TNF-alpha, IL-1 beta, and IL-6, all key players in the body’s inflammatory response, are found at altered levels in trigeminal neuralgia patients. A genetic analysis found that elevated levels of two specific immune signaling chemicals (a skin-targeting chemokine called CTACK and an interferon-related molecule called MIG) are associated with increased trigeminal neuralgia risk.
In autoimmune connective tissue diseases, the proposed mechanism is different from simple compression. The leading theories involve immune complexes (clusters of antibodies) depositing in the sensory nerve root, or inflammation of the tiny blood vessels that supply the nerve itself, cutting off its blood supply. Both pathways lead to the same outcome: damage to the nerve’s insulation and the misfiring that causes pain.
What This Means if You Have TN
If you have trigeminal neuralgia and are wondering whether an autoimmune condition might be behind it, context matters. Classical trigeminal neuralgia typically affects one side of the face, most commonly the second and third branches of the nerve (the cheek, jaw, and lower face), and brain imaging shows a blood vessel compressing the nerve. If your imaging is normal, showing no vascular compression, that raises the question of whether something else is driving the nerve damage.
Certain features make an autoimmune or secondary cause more likely: pain on both sides of the face, numbness or reduced sensation between pain attacks, younger age at onset, or existing symptoms like dry eyes, dry mouth, joint pain, skin changes, or fatigue that could point to a connective tissue disease. In case series where patients had trigeminal neuralgia from autoimmune causes, normal brain imaging (ruling out vascular compression) was a consistent finding, and the TN sometimes preceded the autoimmune diagnosis by months or years.
The distinction matters for treatment. Classical trigeminal neuralgia caused by vascular compression can be treated with medications that calm nerve firing, and in refractory cases, surgery to move the offending blood vessel away from the nerve. When an autoimmune disease is the root cause, treating the underlying inflammation and immune dysfunction becomes central to managing the facial pain. Medications that work well for compression-related TN may be less effective if the immune system is actively damaging the nerve.